Simplex Trading, LLC Acer Therapeutics Inc. Transaction History

Simplex Trading, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	BUY	$0.57 - $1.28 $284 - $638	499 Added 34.51%	1,945 $1,000
Q2 2023 Aug 04, 2023	SELL	$0.75 - $1.14 $1,104 - $1,678	-1,472 Reduced 50.45%	1,446 $1,000
Q1 2023 Apr 27, 2023	SELL	$0.67 - $3.05 $5,516 - $25,113	-8,234 Reduced 73.83%	2,918 $2,000
Q4 2022 Feb 02, 2023	SELL	$1.13 - $4.15 $1,949 - $7,158	-1,725 Reduced 13.4%	11,152 $27,000
Q3 2022 Nov 04, 2022	BUY	$1.28 - $1.6 $13,038 - $16,297	10,186 Added 378.52%	12,877 $17,000
Q2 2022 Aug 03, 2022	BUY	$1.19 - $3.04 $2,914 - $7,444	2,449 Added 1011.98%	2,691 $3,000
Q1 2022 May 02, 2022	SELL	$1.98 - $2.98 $18,511 - $27,860	-9,349 Reduced 97.48%	242 $0
Q2 2021 Aug 12, 2021	SELL	$2.52 - $3.18 $17,869 - $22,549	-7,091 Reduced 42.51%	9,591 $27,000
Q1 2021 Apr 26, 2021	BUY	$2.47 - $4.39 $39,151 - $69,585	15,851 Added 1907.46%	16,682 $51,000
Q4 2020 Feb 02, 2021	BUY	$2.34 - $2.99 $1,944 - $2,484	831 New	831 $2,000

365

Ticker ACER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,100,000
Description
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.